thromboplastin and Neuroendocrine-Tumors

thromboplastin has been researched along with Neuroendocrine-Tumors* in 1 studies

Other Studies

1 other study(ies) available for thromboplastin and Neuroendocrine-Tumors

Article	Year
mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors. Journal of thrombosis and haemostasis : JTH, 2019, Volume: 17, Issue:1 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice, Nude; Neuroendocrine Tumors; Pancreatic Neoplasms; Promoter Regions, Genetic; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Signal Transduction; Thromboplastin; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays	2019

Article

Year

mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors.

Journal of thrombosis and haemostasis : JTH, 2019, Volume: 17, Issue:1

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice, Nude; Neuroendocrine Tumors; Pancreatic Neoplasms; Promoter Regions, Genetic; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Signal Transduction; Thromboplastin; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays

2019